
Subhani Sheik
About Subhani Sheik
Data last updated:
Subhani Sheik is a Director at Bhavyas Pharmaceuticals Private Limited (since 2025) and Designated Partner at Aion Pharma Llp (since 2017). The companies operate in Pharma. The largest current company by reported revenue is Bhavyas Pharmaceuticals Private Limited at ₹2.83 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 20 Nov 2025 | 2019 | ₹2.83 Cr (FY 2025) | Active | |
| Designated Partner | 09 Mar 2017 | 2017 | Active |
Board colleagues of Subhani Sheik
| Name | DIN | Company | Designation |
|---|---|---|---|
| Anji Reddy Nandipati | 08433778 | Bhavyas Pharmaceuticals Private Limited | Director |
| Mandepudi Kirankumar | 08592391 | Bhavyas Pharmaceuticals Private Limited | Director |
| Naresh Ponduri | 08433779 | Bhavyas Pharmaceuticals Private Limited | Director |
| Samba Sivarao Arigela | 07074454 | Bhavyas Pharmaceuticals Private Limited | Director |
| Suhani Sheik | 07746980 | Aion Pharma Llp | Designated Partner |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Subhani Sheik
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Subhani Sheik
Subhani Sheik currently holds 2 directorships: Bhavyas Pharmaceuticals Private Limited (Director, since 20 Nov 2025, revenue ₹2.83 Cr (FY 2025)); Aion Pharma Llp (Designated Partner, since 09 Mar 2017).
Subhani Sheik was first appointed on 09 Mar 2017 as Designated Partner at Aion Pharma Llp. The most recent appointment on record is 20 Nov 2025 at Bhavyas Pharmaceuticals Private Limited.
The current boards of Subhani Sheik's companies include Anji Reddy Nandipati (Bhavyas Pharmaceuticals Private Limited), Mandepudi Kirankumar (Bhavyas Pharmaceuticals Private Limited), Naresh Ponduri (Bhavyas Pharmaceuticals Private Limited), Samba Sivarao Arigela (Bhavyas Pharmaceuticals Private Limited), Suhani Sheik (Aion Pharma Llp).